{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:37:49Z","timestamp":1791409069492,"version":"4.3.3"},"reference-count":191,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010621","name":"Uniwersytet Medyczny w Lublinie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ethnopharmacology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jep.2023.116740","type":"journal-article","created":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T11:29:22Z","timestamp":1686569362000},"page":"116740","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Natural product-derived therapies for treating drug-resistant epilepsies: From ethnopharmacology to evidence-based medicine"],"prefix":"10.1016","volume":"317","author":[{"given":"Soura","family":"Challal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrianna","family":"Skiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Langlois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila V.","family":"Esguerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Wolfender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander D.","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9313-5929","authenticated-orcid":false,"given":"Krystyna","family":"Skalicka-Wo\u017aniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jep.2023.116740_bib1","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/692751","article-title":"Efficacy of Iranian traditional medicine in the treatment of epilepsy","volume":"2013","author":"Abdollahi Fard","year":"2013","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.jep.2023.116740_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2012.06.010","article-title":"Epilepsy in the Renaissance: a survey of remedies from 16th and 17th century German herbals","author":"Adams","year":"2012","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jep.2023.116740_bib3","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1472-8206.2011.01002.x","article-title":"Liposomal formulation of curcumin attenuates seizures in different experimental models of epilepsy in mice","volume":"27","author":"Agarwal","year":"2013","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.jep.2023.116740_bib4","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/ptr.5048","article-title":"Effect of curcumin against pentylenetetrazol-induced seizure threshold in mice: possible involvement of adenosine A1 receptors","volume":"28","author":"Akula","year":"2014","journal-title":"Phytother Res."},{"key":"10.1016\/j.jep.2023.116740_bib5","article-title":"L-ascorbic acid and curcumin prevents brain damage-induced via lead acetate in rats: possible mechanisms","author":"Alhusaini","year":"2021","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.jep.2023.116740_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2006-960004","article-title":"Pharmacology of curcuma longa","volume":"57","author":"Ammon","year":"1991","journal-title":"Planta Med."},{"key":"10.1016\/j.jep.2023.116740_bib7","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.neuro.2010.06.007","article-title":"Soman increases neuronal COX-2 levels: possible link between seizures and protracted neuronal damage","volume":"31","author":"Angoa-P\u00e9rez","year":"2010","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.jep.2023.116740_bib8","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/cts.13425","article-title":"The safety and efficacy of low oral doses of cannabidiol: an evaluation of the evidence","volume":"16","author":"Arnold","year":"2023","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.jep.2023.116740_bib10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jep.2018.12.049","article-title":"Herbal medicine for epilepsy seizures in Asia, Africa and Latin America: a systematic review","volume":"234","author":"Auditeau","year":"2019","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jep.2023.116740_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2020.107447","article-title":"Quality of life in patients with epilepsy or psychogenic nonepileptic seizures and the contribution of psychiatric comorbidities","volume":"112","author":"Avalos","year":"2020","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.jep.2023.116740_bib12","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1111\/1750-3841.14317","article-title":"Quercetin in food: possible mechanisms of its effect on memory","volume":"83","author":"Babaei","year":"2018","journal-title":"J. Food Sci."},{"key":"10.1016\/j.jep.2023.116740_bib13","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.lfs.2005.09.012","article-title":"Drug discovery from medicinal plants","volume":"78","author":"Balunas","year":"2005","journal-title":"Life Sci."},{"key":"10.1016\/j.jep.2023.116740_bib14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0920-1211(01)00302-3","article-title":"Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy","volume":"47","author":"Barton","year":"2001","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.jep.2023.116740_bib15","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/0006-8993(79)90163-X","article-title":"A new model of focal status epilepticus: intra-amygdaloid application of kainic acid elicits repetitive secondarily generalized convulsive seizures","volume":"163","author":"Ben-Ari","year":"1979","journal-title":"Brain Res."},{"key":"10.1016\/j.jep.2023.116740_bib17","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1111\/epi.16726","article-title":"Progress report on new antiepileptic drugs: a summary of the Fifteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XV). II. Drugs in more advanced clinical development","volume":"61","author":"Bialer","year":"2020","journal-title":"Epilepsia"},{"key":"10.1016\/j.jep.2023.116740_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2006.10.008","article-title":"Progress report on new antiepileptic drugs: a summary of the Eigth Eilat Conference (EILAT VIII)","author":"Bialer","year":"2007","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.jep.2023.116740_bib19","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.eplepsyres.2015.01.001","article-title":"Progress report on new antiepileptic drugs: a summary of the Twelfth Eilat Conference (EILAT XII)","volume":"111","author":"Bialer","year":"2015","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.jep.2023.116740_bib20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.eplepsyres.2010.09.001","article-title":"Progress report on new antiepileptic drugs: a summary of the Tenth Eilat Conference (EILAT X)","volume":"92","author":"Bialer","year":"2010","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.jep.2023.116740_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2008.09.005","article-title":"Progress report on new antiepileptic drugs: a summary of the Ninth Eilat Conference (EILAT IX)","author":"Bialer","year":"2009","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.jep.2023.116740_bib22","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nrd2997","article-title":"Key factors in the discovery and development of new antiepileptic drugs","volume":"9","author":"Bialer","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jep.2023.116740_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064006","article-title":"Integration of Microfractionation, qNMR and zebrafish screening for the in vivo bioassay-guided isolation and quantitative bioactivity analysis of natural products","volume":"8","author":"Bohni","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jep.2023.116740_bib24","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1089\/can.2019.0003","article-title":"Comparison of the neurotoxic and seizure-inducing effects of synthetic and endogenous cannabinoids with \u0394(9)-tetrahydrocannabinol","volume":"5","author":"Breivogel","year":"2020","journal-title":"Cannabis cannabinoid Res"},{"key":"10.1016\/j.jep.2023.116740_bib25","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1212\/WNL.0b013e3182563b19","article-title":"Patterns of treatment response in newly diagnosed epilepsy","volume":"78","author":"Brodie","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.jep.2023.116740_bib27","first-page":"789","article-title":"The analgesic and anticonvulsant effects of piperine in mice","volume":"64","author":"Bukhari","year":"2013","journal-title":"J. Physiol. Pharmacol. an Off. J. Polish Physiol. Soc."},{"key":"10.1016\/j.jep.2023.116740_bib28","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.yebeh.2008.12.022","article-title":"Validation of anticonvulsant and sedative activity of six medicinal plants","volume":"14","author":"Bum","year":"2009","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.jep.2023.116740_bib29","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1055\/s-0031-1298434","article-title":"What is the best strategy for preclinical testing of botanicals? A critical perspective","volume":"78","author":"Butterweck","year":"2012","journal-title":"Planta Med."},{"key":"10.1016\/j.jep.2023.116740_bib30","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.phrs.2016.01.033","article-title":"Cannabidiol, neuroprotection and neuropsychiatric disorders","volume":"112","author":"Campos","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jep.2023.116740_bib31","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1179\/1476830511Y.0000000034","article-title":"Curcumin protects against the oxidative damage induced by the pesticide parathion in the hippocampus of the rat brain","volume":"15","author":"Canales-Aguirre","year":"2012","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.jep.2023.116740_bib32","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0022-3565(24)36511-5","article-title":"Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3alpha-hydroxy-3beta-methyl-5alpha-pregnan-20-one), a selective, high-affinity, steroid modulator of the gamma-aminobutyric acid(A) receptor","volume":"280","author":"Carter","year":"1997","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.jep.2023.116740_bib33","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1476-5381.2009.00515.x","article-title":"Evidence that the plant cannabinoid cannabigerol is a highly potent alpha2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist","volume":"159","author":"Cascio","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jep.2023.116740_bib34","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/epi4.12386","article-title":"Neurodegenerative pathways as targets for acquired epilepsy therapy development","volume":"5","author":"Casillas-Espinosa","year":"2020","journal-title":"Epilepsia open"},{"key":"10.1016\/j.jep.2023.116740_bib38","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/epi.12635","article-title":"The case for assessing cannabidiol in epilepsy","volume":"55","author":"Cilio","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.jep.2023.116740_bib39","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cbi.2008.05.023","article-title":"[+]-Huperzine A treatment protects against N-methyl-D-aspartate-induced seizure\/status epilepticus in rats","volume":"175","author":"Coleman","year":"2008","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.jep.2023.116740_bib40","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.bbr.2008.02.043","article-title":"Long-term consequences of soman poisoning in mice Part 1. Neuropathology and neuronal regeneration in the amygdala","volume":"191","author":"Collombet","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.jep.2023.116740_bib41","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0022-3565(25)30824-4","article-title":"Cannabidiol--antiepileptic drug comparisons and interactions in experimentally induced seizures in rats","volume":"201","author":"Consroe","year":"1977","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.jep.2023.116740_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2006.09.030","article-title":"Potential therapeutical effects of cannabidiol in children with pharmacoresistant epilepsy","author":"Cortesi","year":"2007","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.jep.2023.116740_bib44","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41582-019-0284-z","article-title":"Cannabinoids and the expanded endocannabinoid system in neurological disorders","volume":"16","author":"Cristino","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jep.2023.116740_bib45","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S2352-4642(18)30099-3","article-title":"Adjunctive everolimus for children and adolescents with treatment-refractory seizures associated with tuberous sclerosis complex: post-hoc analysis of the phase 3 EXIST-3 trial","volume":"2","author":"Curatolo","year":"2018","journal-title":"Lancet. Child Adolesc. Heal."},{"key":"10.1016\/j.jep.2023.116740_bib46","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1021\/np900009b","article-title":"NMR quantitation of natural products at the nanomole scale","volume":"72","author":"Dalisay","year":"2009","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.jep.2023.116740_bib47","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/cpt.2408","article-title":"Pharmacogenetic predictors of cannabidiol response and tolerability in treatment-resistant epilepsy","volume":"110","author":"Davis","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jep.2023.116740_bib48","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/dta.1425","article-title":"Medical use of cannabis. Cannabidiol: a new light for schizophrenia?","volume":"5","author":"Deiana","year":"2013","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jep.2023.116740_bib49","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.neurol.2021.06.004","article-title":"Relationships between migraine and epilepsy: pathophysiological mechanisms and clinical implications","volume":"177","author":"Demarquay","year":"2021","journal-title":"Rev. Neurol. (Paris)"},{"key":"10.1016\/j.jep.2023.116740_bib50","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11910-015-0586-5","article-title":"Marijuana use in epilepsy: the myth and the reality","volume":"15","author":"Detyniecki","year":"2015","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.jep.2023.116740_bib51","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/epi.12631","article-title":"Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders","volume":"55","author":"Devinsky","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.jep.2023.116740_bib52","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1056\/NEJMoa1611618","article-title":"Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome","volume":"376","author":"Devinsky","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jep.2023.116740_bib53","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/epi.14628","article-title":"Long-term cannabidiol treatment in patients with Dravet syndrome: an open-label extension trial","volume":"60","author":"Devinsky","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.jep.2023.116740_bib54","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.3390\/ph3051426","article-title":"Natural products in epilepsy-the present situation and perspectives for the future","volume":"3","author":"Ekstein","year":"2010","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jep.2023.116740_bib55","article-title":"Curcumin synergizes with cisplatin to inhibit colon cancer through targeting the MicroRNA-137-glutaminase Axis","author":"Fan","year":"2021","journal-title":"Curr. Med. Sci."},{"key":"10.1016\/j.jep.2023.116740_bib56","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11101-014-9384-y","article-title":"Huperzine A from Huperzia serrata: a review of its sources, chemistry, pharmacology and toxicology","volume":"15","author":"Ferreira","year":"2016","journal-title":"Phytochemistry Rev."},{"key":"10.1016\/j.jep.2023.116740_bib57","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0022-3565(25)11863-6","article-title":"Central activity and structure in a series of water-soluble steroids","volume":"119","author":"Figdor","year":"1957","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.jep.2023.116740_bib58","doi-asserted-by":"crossref","DOI":"10.1111\/epi.12550","article-title":"ILAE Official Report: a practical clinical definition of epilepsy","author":"Fisher","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.jep.2023.116740_bib59","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1056\/NEJMra1407304","article-title":"Cannabinoids in the treatment of epilepsy","volume":"373","author":"Friedman","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jep.2023.116740_bib60","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1248\/bpb.33.598","article-title":"Neuroprotective effect of piperine on primarily cultured hippocampal neurons","volume":"33","author":"Fu","year":"2010","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jep.2023.116740_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.taap.2017.10.007","article-title":"Synthetic cannabinoid AM2201 induces seizures: involvement of cannabinoid CB(1) receptors and glutamatergic transmission","volume":"338","author":"Funada","year":"2018","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.jep.2023.116740_bib62","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1001\/archgenpsychiatry.2008.519","article-title":"Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing","volume":"66","author":"Fusar-Poli","year":"2009","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.jep.2023.116740_bib63","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1528-1167.2012.03506.x","article-title":"Finding a better drug for epilepsy: the mTOR pathway as an antiepileptogenic target","volume":"53","author":"Galanopoulou","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.jep.2023.116740_bib64","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.yebeh.2019.03.035","article-title":"Quality of life in adults enrolled in an open-label study of cannabidiol (CBD) for treatment-resistant epilepsy","volume":"95","author":"Gaston","year":"2019","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.jep.2023.116740_bib66","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.eplepsyres.2015.08.012","article-title":"Huperzine A prophylaxis against pentylenetetrazole-induced seizures in rats is associated with increased cortical inhibition","volume":"117","author":"Gersner","year":"2015","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.jep.2023.116740_bib67","first-page":"325","article-title":"Pharmacological and molecular evidence of neuroprotective curcumin effects against biochemical and behavioral sequels caused by methamphetamine: possible function of CREB-BDNF signaling pathway","volume":"12","author":"Gholami","year":"2021","journal-title":"Basic Clin. Neurosci."},{"key":"10.1016\/j.jep.2023.116740_bib68","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/epi.12074","article-title":"Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes","volume":"54","author":"Glauser","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.jep.2023.116740_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2020.106525","article-title":"Cannabidiolic acid exhibits entourage-like improvements of anticonvulsant activity in an acute rat model of seizures","volume":"169","author":"Goerl","year":"2021","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.jep.2023.116740_bib70","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-3-030-57369-0_7","article-title":"Cannabidiol therapy for refractory epilepsy and seizure disorders","volume":"1264","author":"Golub","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"issue":"Suppl. 1","key":"10.1016\/j.jep.2023.116740_bib72","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1002\/jat.805","article-title":"The NMDA receptor ion channel: a site for binding of Huperzine A","volume":"21","author":"Gordon","year":"2001","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.jep.2023.116740_bib73","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3389\/fpsyt.2019.00303","article-title":"Suicidal ideation and traumatic exposure should not Be neglected in epileptic patients: a multidimensional comparison of the psychiatric profile of patients suffering from epilepsy and patients suffering from psychogenic nonepileptic seizures","volume":"10","author":"Guillen","year":"2019","journal-title":"Front. psychiatry"},{"key":"10.1016\/j.jep.2023.116740_bib74","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1038\/s41598-017-03032-0","article-title":"Rapamycin attenuates acute seizure-induced astrocyte injury in mice in vivo","volume":"7","author":"Guo","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jep.2023.116740_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045156","article-title":"The mTOR inhibitor rapamycin has limited acute anticonvulsant effects in mice","volume":"7","author":"Hartman","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jep.2023.116740_bib77","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.phrs.2010.05.001","article-title":"Quercetin supplementation and upper respiratory tract infection: a randomized community clinical trial","volume":"62","author":"Heinz","year":"2010","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jep.2023.116740_bib78","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.pharmthera.2011.09.002","article-title":"Phytocannabinoids as novel therapeutic agents in CNS disorders","volume":"133","author":"Hill","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jep.2023.116740_bib79","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s40618-014-0096-3","article-title":"Review of the protective effects of rutin on the metabolic function as an important dietary flavonoid","volume":"37","author":"Hosseinzadeh","year":"2014","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.jep.2023.116740_bib81","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ng1494","article-title":"Dysregulation of the TSC-mTOR pathway in human disease","volume":"37","author":"Inoki","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jep.2023.116740_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.fitote.2019.104277","article-title":"Lycopodium alkaloids from Huperzia serrata","volume":"137","author":"Jiang","year":"2019","journal-title":"Fitoterapia"},{"key":"10.1016\/j.jep.2023.116740_bib83","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1742-2094-7-40","article-title":"The acute phase response and soman-induced status epilepticus: temporal, regional and cellular changes in rat brain cytokine concentrations","volume":"7","author":"Johnson","year":"2010","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jep.2023.116740_bib84","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.seizure.2012.03.001","article-title":"Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures","volume":"21","author":"Jones","year":"2012","journal-title":"Seizure"},{"key":"10.1016\/j.jep.2023.116740_bib85","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.yebeh.2015.06.017","article-title":"The importance of botanical treatments in traditional societies and challenges in developing countries","volume":"52","author":"Kakooza-Mwesige","year":"2015","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.jep.2023.116740_bib88","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S2221-1691(13)60060-X","article-title":"Bioavailability enhancers of herbal origin: an overview","volume":"3","author":"Kesarwani","year":"2013","journal-title":"Asian Pac. J. Trop. Biomed."},{"key":"10.1016\/j.jep.2023.116740_bib89","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1007\/s11064-017-2287-8","article-title":"Evaluation of cannabidiol in animal seizure models by the epilepsy therapy screening program (ETSP)","volume":"42","author":"Klein","year":"2017","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.jep.2023.116740_bib90","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1474-4422(22)00077-1","article-title":"Safety and efficacy of ganaxolone in patients with CDKL5 deficiency disorder: results from the double-blind phase of a randomised, placebo-controlled, phase 3 trial","volume":"21","author":"Knight","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jep.2023.116740_bib91","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.150120","article-title":"Identifying the temporal electrophysiological and molecular changes that contribute to TSC-associated epileptogenesis","volume":"6","author":"Koene","year":"2021","journal-title":"JCI insight"},{"key":"10.1016\/j.jep.2023.116740_bib92","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/s41598-021-04741-3","article-title":"Neuropsychopharmacological profiling of scoparone in mice","volume":"12","author":"Kowalczyk","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jep.2023.116740_bib93","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1152\/jn.00128.2020","article-title":"Cannabidiol activation of vagal afferent neurons requires TRPA1","volume":"124","author":"Kowalski","year":"2020","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.jep.2023.116740_bib95","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.eplepsyres.2018.12.007","article-title":"Curcumin's antiepileptic effect, and alterations in Na(v)1.1 and Na(v)1.6 expression in iron-induced epilepsy","volume":"150","author":"Kumar","year":"2019","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.jep.2023.116740_bib96","doi-asserted-by":"crossref","first-page":"11288","DOI":"10.1523\/JNEUROSCI.2284-05.2005","article-title":"Regulation of dendritic morphogenesis by Ras-PI3K-Akt-mTOR and Ras-MAPK signaling pathways","volume":"25","author":"Kumar","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jep.2023.116740_bib97","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.jep.2023.116740_bib99","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/0006-8993(91)91539-D","article-title":"Effects of soman-induced seizures on different extracellular amino acid levels and on glutamate uptake in rat hippocampus","volume":"563","author":"Lallement","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.jep.2023.116740_bib100","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1081\/DCT-120005893","article-title":"Subchronic administration of pyridostigmine or huperzine to primates: compared efficacy against soman toxicity","volume":"25","author":"Lallement","year":"2002","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.jep.2023.116740_bib102","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1007\/s40265-018-0992-5","article-title":"Efficacy and safety of cannabidiol in epilepsy: a systematic review and meta-analysis","volume":"78","author":"Lattanzi","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.jep.2023.116740_bib103","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1080\/14737175.2021.1904895","article-title":"Ganaxolone treatment for epilepsy patients: from pharmacology to place in therapy","volume":"21","author":"Lattanzi","year":"2021","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.jep.2023.116740_bib104","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.eplepsyres.2019.03.015","article-title":"Long-term safety and efficacy of cannabidiol in children and adults with treatment resistant Lennox-Gastaut syndrome or Dravet syndrome: expanded access program results","volume":"154","author":"Laux","year":"2019","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.jep.2023.116740_bib105","first-page":"1187","article-title":"Assessment of ganaxolone's anticonvulsant activity using a randomized, double-blind, presurgical trial design","volume":"41","author":"Laxer","year":"2000","journal-title":"Ganaxolone Presurgical Study Group. Epilepsia"},{"key":"10.1016\/j.jep.2023.116740_bib106","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.yebeh.2015.03.019","article-title":"Cross-species pharmacological characterization of the allylglycine seizure model in mice and larval zebrafish","volume":"45","author":"Leclercq","year":"2015","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.jep.2023.116740_bib107","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jconrel.2021.01.033","article-title":"Hyaluronic acid and albumin based nanoparticles for drug delivery","volume":"331","author":"Lei","year":"2021","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.jep.2023.116740_bib108","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S1474-4422(22)00035-7","article-title":"CDKL5 deficiency disorder: clinical features, diagnosis, and management","volume":"21","author":"Leonard","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jep.2023.116740_bib109","article-title":"Ketogenic diets and protective mechanisms in epilepsy, metabolic disorders, cancer, neuronal loss, and muscle and nerve degeneration","volume":"44","author":"Li","year":"2020","journal-title":"J. Food Biochem."},{"key":"10.1016\/j.jep.2023.116740_bib110","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF03191002","article-title":"Pharmacokinetics of huperzine A following oral administration to human volunteers","volume":"32","author":"Li","year":"2007","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.jep.2023.116740_bib111","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S1525-5050(02)00523-1","article-title":"Clinical presentations of naturally occurring canine seizures: similarities to human seizures","volume":"3","author":"Licht","year":"2002","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.jep.2023.116740_bib112","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.682821","article-title":"Chinese herbal medicine for treating epilepsy","volume":"15","author":"Lin","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.jep.2023.116740_bib113","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1242\/dmm.002386","article-title":"Rapamycin suppresses seizures and neuronal hypertrophy in a mouse model of cortical dysplasia","volume":"2","author":"Ljungberg","year":"2009","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.jep.2023.116740_bib114","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1007\/s11064-017-2222-z","article-title":"Animal models of seizures and epilepsy: past, present, and future role for the discovery of antiseizure drugs","volume":"42","author":"L\u00f6scher","year":"2017","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.jep.2023.116740_bib115","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1124\/pr.120.019539","article-title":"Drug resistance in epilepsy: clinical impact, potential mechanisms, and new innovative treatment options","volume":"72","author":"L\u00f6scher","year":"2020","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jep.2023.116740_bib116","doi-asserted-by":"crossref","DOI":"10.1111\/j.1528-1167.2011.03024.x","article-title":"Modern antiepileptic drug development has failed to deliver: ways out of the current dilemma","author":"L\u00f6scher","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.jep.2023.116740_bib117","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jep.2007.05.030","article-title":"Huperzine A from Huperzia species--an ethnopharmacolgical review","volume":"113","author":"Ma","year":"2007","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jep.2023.116740_bib118","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0014-2999(03)01290-1","article-title":"Identification of cytochrome P450 1A2 as enzyme involved in the microsomal metabolism of Huperzine A","volume":"461","author":"Ma","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jep.2023.116740_bib120","first-page":"626","article-title":"Medical marijuana in the pediatric population with epilepsy-what you should know","volume":"33","author":"Markle","year":"2019","journal-title":"J. Pediatr. Heal. care Off. Publ. Natl. Assoc. Pediatr. Nurse Assoc. Pract."},{"key":"10.1016\/j.jep.2023.116740_bib121","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0140-6736(07)60460-7","article-title":"The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial","volume":"369","author":"Marson","year":"2007","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.jep.2023.116740_bib122","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0140-6736(07)60461-9","article-title":"The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial","volume":"369","author":"Marson","year":"2007","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.jep.2023.116740_bib123","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00221-005-0068-0","article-title":"Curcumin treatment protects rat retinal neurons against excitotoxicity: effect on N-methyl-D: -aspartate-induced intracellular Ca(2+) increase","volume":"167","author":"Matteucci","year":"2005","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.jep.2023.116740_bib125","doi-asserted-by":"crossref","first-page":"11S","DOI":"10.1002\/j.1552-4604.2002.tb05998.x","article-title":"Cannabidiol: an overview of some pharmacological aspects","volume":"42","author":"Mechoulam","year":"2002","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.jep.2023.116740_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105423","article-title":"Proteomic signature of the Dravet syndrome in the genetic Scn1a-A1783V mouse model","volume":"157","author":"Miljanovic","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jep.2023.116740_bib127","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/1440-1681.13064","article-title":"Huperzine A ameliorates cognitive dysfunction and neuroinflammation in kainic acid-induced epileptic rats by antioxidant activity and NLRP3\/caspase-1 pathway inhibition","volume":"46","author":"Mohseni-Moghaddam","year":"2019","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.jep.2023.116740_bib128","first-page":"124","article-title":"The anticonvulsant and antioxidant effects of berberine in kainate-induced temporal lobe epilepsy in rats","volume":"5","author":"Mojarad","year":"2014","journal-title":"Basic Clin. Neurosci."},{"key":"10.1016\/j.jep.2023.116740_bib129","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1517\/13543784.8.10.1663","article-title":"Ganaxolone: a novel positive allosteric modulator of the GABA(A) receptor complex for the treatment of epilepsy","volume":"8","author":"Monaghan","year":"1999","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.jep.2023.116740_bib130","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/j.1528-1157.1997.tb01486.x","article-title":"Initial human experience with ganaxolone, a neuroactive steroid with antiepileptic activity","volume":"38","author":"Monaghan","year":"1997","journal-title":"Epilepsia"},{"key":"10.1016\/j.jep.2023.116740_bib132","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jep.2004.11.015","article-title":"Plants used to treat epilepsy by Tanzanian traditional healers","volume":"97","author":"Moshi","year":"2005","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jep.2023.116740_bib133","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1177\/0883073808324535","article-title":"Rapamycin reduces seizure frequency in tuberous sclerosis complex","volume":"24","author":"Muncy","year":"2009","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.jep.2023.116740_bib134","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/271676a0","article-title":"Intraventricular kainic acid preferentially destroys hippocampal pyramidal cells","volume":"271","author":"Nadler","year":"1978","journal-title":"Nature"},{"key":"10.1016\/j.jep.2023.116740_bib135","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3736\/jintegrmed2013042","article-title":"Effects of rutin on oxidative stress in mice with kainic acid-induced seizure","volume":"11","author":"Nassiri-Asl","year":"2013","journal-title":"J. Integr. Med."},{"key":"10.1016\/j.jep.2023.116740_bib136","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1039\/a902202c","article-title":"The influence of natural products upon drug discovery","volume":"17","author":"Newman","year":"2000","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.jep.2023.116740_bib137","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.pnpbp.2014.05.007","article-title":"Effect of quercetin and rutin in some acute seizure models in mice","volume":"54","author":"Nieoczym","year":"2014","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jep.2023.116740_bib138","first-page":"102","volume":"4","author":"Nohria","year":"2007","journal-title":"Ganaxolone. Neurother. J. Am. Soc. Exp. Neurother."},{"key":"10.1016\/j.jep.2023.116740_bib139","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/seiz.1999.0378","article-title":"Review on phytotherapy in epilepsy","volume":"9","author":"Nsour","year":"2000","journal-title":"Seizure"},{"key":"10.1016\/j.jep.2023.116740_bib140","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1200\/JCO.2007.14.0988","article-title":"Phase I pharmacokinetic and pharmacodynamic study of the oral mammalian target of rapamycin inhibitor everolimus in patients with advanced solid tumors","volume":"26","author":"O'Donnell","year":"2008","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.jep.2023.116740_bib141","first-page":"181","article-title":"Evaluation of the sedative and anticonvulsant properties of three Cameroonian plants","volume":"8","author":"Okomolo","year":"2011","journal-title":"African J. Tradit. Complement. Altern. Med. AJTCAM"},{"key":"10.1016\/j.jep.2023.116740_bib142","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081634","article-title":"Insights from zebrafish and mouse models on the activity and safety of ar-turmerone as a potential drug candidate for the treatment of epilepsy","volume":"8","author":"Orellana-Paucar","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jep.2023.116740_bib144","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.neulet.2009.12.033","article-title":"Intrathecal huperzine A increases thermal escape latency and decreases flinching behavior in the formalin test in rats","volume":"470","author":"Park","year":"2010","journal-title":"Neurosci. Lett."},{"issue":"Suppl. 1","key":"10.1016\/j.jep.2023.116740_bib145","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1002\/jat.818","article-title":"Soman-induced seizures: limbic activity, oxidative stress and neuroprotective proteins","volume":"21","author":"Pazdernik","year":"2001","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.jep.2023.116740_bib146","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jep.2008.11.006","article-title":"Pharmacological screening of Malian medicinal plants used against epilepsy and convulsions","volume":"121","author":"Pedersen","year":"2009","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jep.2023.116740_bib147","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1111\/j.1528-1167.2010.02657.x","article-title":"Infantile spasms: a U.S. consensus report","volume":"51","author":"Pellock","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.jep.2023.116740_bib148","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","article-title":"The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin","volume":"153","author":"Pertwee","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jep.2023.116740_bib149","article-title":"Ganaxolone significantly reduces major motor seizures associated with CDKL5 deficiency disorder : a randomized , double-blind","author":"Pestana-knight","year":"2020","journal-title":"Placebo-Controlled Phase 3 Study (Marigold Study) 2020"},{"key":"10.1016\/j.jep.2023.116740_bib150","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1111\/j.1528-1167.2007.01182.x","article-title":"Clinical evaluation of ganaxolone in pediatric and adolescent patients with refractory epilepsy","volume":"48","author":"Pieribone","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.jep.2023.116740_bib151","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153422","article-title":"Monoterpenes as a perspective for the treatment of seizures: a Systematic Review","volume":"81","author":"Pina","year":"2021","journal-title":"Phytomedicine"},{"issue":"Suppl. 3","key":"10.1016\/j.jep.2023.116740_bib152","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1528-1167.2010.02602.x","article-title":"Therapeutic approaches to epileptogenesis--hope on the horizon","volume":"51","author":"Pitk\u00e4nen","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.jep.2023.116740_bib153","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1111\/epi.16878","article-title":"Time to onset of cannabidiol (CBD) treatment effect in Lennox-Gastaut syndrome: analysis from two randomized controlled trials","volume":"62","author":"Privitera","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/j.jep.2023.116740_bib154","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1590\/S0102-695X2008000500026","article-title":"Plants with anticonvulsant properties - a review","volume":"18","author":"Quintans J\u00fanior","year":"2008","journal-title":"Rev. Bras. Farmacogn."},{"key":"10.1016\/j.jep.2023.116740_bib155","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.apjtb.2016.11.028","article-title":"Anticonvulsant effects of medicinal plants with emphasis on mechanisms of action","volume":"7","author":"Rabiei","year":"2017","journal-title":"Asian Pac. J. Trop. Biomed."},{"key":"10.1016\/j.jep.2023.116740_bib157","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1212\/WNL.0b013e318216eb7b","article-title":"A phase II trial of huperzine A in mild to moderate Alzheimer disease","volume":"76","author":"Rafii","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jep.2023.116740_bib158","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1124\/jpet.104.065268","article-title":"Anticonvulsant activity of progesterone and neurosteroids in progesterone receptor knockout mice","volume":"310","author":"Reddy","year":"2004","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.jep.2023.116740_bib159","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1007\/s12272-013-0205-4","article-title":"Quercetin along with piperine prevents cognitive dysfunction, oxidative stress and neuro-inflammation associated with mouse model of chronic unpredictable stress","volume":"40","author":"Rinwa","year":"2017","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.jep.2023.116740_bib161","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1007\/s12035-012-8314-5","article-title":"The mTOR signaling pathway in the brain: focus on epilepsy and epileptogenesis","volume":"46","author":"Russo","year":"2012","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jep.2023.116740_bib162","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s11064-005-6978-1","article-title":"Agonistic properties of cannabidiol at 5-HT1a receptors","volume":"30","author":"Russo","year":"2005","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.jep.2023.116740_bib164","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s11910-012-0276-5","article-title":"Mammalian target of rapamycin (mTOR) inhibition: potential for antiseizure, antiepileptogenic, and epileptostatic therapy","volume":"12","author":"Ryther","year":"2012","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.jep.2023.116740_bib165","doi-asserted-by":"crossref","DOI":"10.1016\/j.seizure.2014.01.013","article-title":"Medicinal plants used in Iranian traditional medicine to treat epilepsy","author":"Sahranavard","year":"2014","journal-title":"Seizure"},{"key":"10.1016\/j.jep.2023.116740_bib166","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.pediatrneurol.2019.10.009","article-title":"PCDH19-Related epilepsy syndrome: a comprehensive clinical review","volume":"105","author":"Samanta","year":"2020","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.jep.2023.116740_bib168","series-title":"Novel Treatment of Epilepsy. IntechOpen, Rijeka","article-title":"Drug discovery in epilepsy: a synthetic review","author":"SanMartin","year":"2011"},{"key":"10.1016\/j.jep.2023.116740_bib170","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1089\/ars.2006.8.395","article-title":"Curcumin activates defensive genes and protects neurons against oxidative stress","volume":"8","author":"Scapagnini","year":"2006","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.jep.2023.116740_bib171","first-page":"343","article-title":"Seizure disorders","volume":"93","author":"Schachter","year":"2009","journal-title":"Med. Clin."},{"key":"10.1016\/j.jep.2023.116740_bib172","doi-asserted-by":"crossref","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: position paper of the ILAE commission for classification and terminology","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"issue":"Suppl. 3","key":"10.1016\/j.jep.2023.116740_bib173","first-page":"S17","article-title":"SCN1A-related phenotypes: epilepsy and beyond","volume":"60","author":"Scheffer","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.jep.2023.116740_bib174","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.yebeh.2009.06.011","article-title":"Clinical use of an herbal-derived compound (Huperzine A) to treat putative complex partial seizures in a dog","volume":"15","author":"Schneider","year":"2009","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.jep.2023.116740_bib175","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/ptr.2625","article-title":"Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders","volume":"23","author":"Scuderi","year":"2009","journal-title":"Phytother Res."},{"key":"10.1016\/j.jep.2023.116740_bib176","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.biopha.2016.12.109","article-title":"Berberine ameliorates intrahippocampal kainate-induced status epilepticus and consequent epileptogenic process in the rat: underlying mechanisms","volume":"87","author":"Sedaghat","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"Suppl. 3","key":"10.1016\/j.jep.2023.116740_bib177","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1528-1167.2009.02041.x","article-title":"Drug treatment of epilepsy in the century of the ILAE: the first 50 years, 1909-1958","volume":"50","author":"Shorvon","year":"2009","journal-title":"Epilepsia"},{"issue":"Suppl. 3","key":"10.1016\/j.jep.2023.116740_bib178","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1528-1167.2009.02042.x","article-title":"Drug treatment of epilepsy in the century of the ILAE: the second 50 years, 1959-2009","volume":"50","author":"Shorvon","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.jep.2023.116740_bib179","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/bcpt.12238","article-title":"Characterization of a lamotrigine-resistant kindled model of epilepsy in mice: evaluation of drug resistance mechanisms","volume":"115","author":"Singh","year":"2014","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.jep.2023.116740_bib180","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2014.09.006","article-title":"Cannabis, cannabidiol, and epilepsies: the truth is somewhere in the middle","author":"Sirven","year":"2014","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.jep.2023.116740_bib181","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/nrn3937","article-title":"Weeding out bad waves: towards selective cannabinoid circuit control in epilepsy","volume":"16","author":"Soltesz","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jep.2023.116740_bib182","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3389\/fneur.2020.00431","article-title":"Piperine attenuates TBI-induced seizures via inhibiting cytokine-activated reactive astrogliosis","volume":"11","author":"Song","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jep.2023.116740_bib183","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.yebeh.2015.05.039","article-title":"Ayurveda and botanical drugs for epilepsy: current evidence and future prospects","volume":"52","author":"Sriranjini","year":"2015","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.jep.2023.116740_bib184","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jep.2008.08.010","article-title":"Review on plants with CNS-effects used in traditional South African medicine against mental diseases","volume":"119","author":"Stafford","year":"2008","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jep.2023.116740_bib185","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1124\/mol.118.111864","article-title":"Cannabidiol inhibits endocannabinoid signaling in autaptic hippocampal neurons","volume":"94","author":"Straiker","year":"2018","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jep.2023.116740_bib186","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1517\/13543780903369341","article-title":"New and investigational antiepileptic drugs","volume":"18","author":"Striano","year":"2009","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.jep.2023.116740_bib187","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.biopha.2016.10.011","article-title":"Bioactive effects of quercetin in the central nervous system: focusing on the mechanisms of actions","volume":"84","author":"Suganthy","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jep.2023.116740_bib188","series-title":"Phase 2 , Placebo-Controlled Clinical Study of Oral Ganaxolone in PCDH19-Clustering Epilepsy 2021","author":"Sullivan","year":"2021"},{"key":"10.1016\/j.jep.2023.116740_bib189","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1111\/j.1528-1167.2011.03280.x","article-title":"Inhibition of the mammalian target of rapamycin blocks epilepsy progression in NS-Pten conditional knockout mice","volume":"52","author":"Sunnen","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.jep.2023.116740_bib190","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.yebeh.2014.08.135","article-title":"Cannabis, cannabidiol, and epilepsy--from receptors to clinical response","volume":"41","author":"Szaflarski","year":"2014","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.jep.2023.116740_bib193","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/sj.bjp.0707133","article-title":"Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro","volume":"150","author":"Thomas","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jep.2023.116740_bib195","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/WCO.0000000000000067","article-title":"Antiepileptogenesis in humans: disappointing clinical evidence and ways to move forward","volume":"27","author":"Trinka","year":"2014","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jep.2023.116740_bib196","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drudis.2006.12.008","article-title":"Targeting mammalian target of rapamycin (mTOR) for health and diseases","volume":"12","author":"Tsang","year":"2007","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jep.2023.116740_bib197","first-page":"113","article-title":"The pharmacology and therapeutic potential of (-)-huperzine A","volume":"4","author":"Tun","year":"2012","journal-title":"J. Exp. Pharmacol."},{"key":"10.1016\/j.jep.2023.116740_bib199","article-title":"Intravenous ganaxolone for the treatment of refractory status epilepticus : results from an open-label , dose-finding","author":"Vaitkevicius","year":"2020","journal-title":"Phase 2 Study 2020"},{"key":"10.1016\/j.jep.2023.116740_bib200","article-title":"Curcumin, Resveratrol and Cannabidiol as natural key-prototypes in drug design for neuroprotective agents","author":"Viegas","year":"2021","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.jep.2023.116740_bib201","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1159\/000017404","article-title":"Cortical dysplasia, genetic abnormalities and neurocutaneous syndromes","volume":"21","author":"Vinters","year":"1999","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.jep.2023.116740_bib202","first-page":"27","article-title":"Anticholinesterase effects of huperzine A, E2020, and tacrine in rats","volume":"19","author":"Wang","year":"1998","journal-title":"Zhongguo Yaoli Xuebao"},{"key":"10.1016\/j.jep.2023.116740_bib203","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/03602532.2017.1306544","article-title":"The metabolism of berberine and its contribution to the pharmacological effects","volume":"49","author":"Wang","year":"2017","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.jep.2023.116740_bib204","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000085387","article-title":"Neuroprotective effects of huperzine A. A natural cholinesterase inhibitor for the treatment of Alzheimer's disease","volume":"14","author":"Wang","year":"2005","journal-title":"Neurosignals"},{"key":"10.1016\/j.jep.2023.116740_bib205","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.cbi.2012.10.016","article-title":"A combination of [+] and [-]-Huperzine A improves protection against soman toxicity compared to [+]-Huperzine A in Guinea pigs","volume":"203","author":"Wang","year":"2013","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.jep.2023.116740_bib206","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/glia.23955","article-title":"The complement C3-C3aR pathway mediates microglia-astrocyte interaction following status epilepticus","volume":"69","author":"Wei","year":"2021","journal-title":"Glia"},{"key":"10.1016\/j.jep.2023.116740_bib207","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1021\/ol400012s","article-title":"A novel synthesis of (-)-huperzine A via tandem intramolecular aza-Prins cyclization-cyclobutane fragmentation","volume":"15","author":"White","year":"2013","journal-title":"Org. Lett."},{"key":"10.1016\/j.jep.2023.116740_bib208","series-title":"WHO | Epilepsy: a Public Health Imperative","year":"2019"},{"key":"10.1016\/j.jep.2023.116740_bib209","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3389\/fphar.2016.00357","article-title":"Huperzine A provides robust and sustained protection against induced seizures in Scn1a mutant mice","volume":"7","author":"Wong","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jep.2023.116740_bib211","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/2630445","article-title":"Curcumin relieves chronic unpredictable mild stress-induced depression-like behavior through the PGC-1\u03b1\/FNDC5\/BDNF pathway","volume":"2021","author":"Wu","year":"2021","journal-title":"Behav. Neurol."},{"key":"10.1016\/j.jep.2023.116740_bib212","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.yebeh.2015.04.050","article-title":"Review of the use of botanicals for epilepsy in complementary medical systems--Traditional Chinese Medicine","volume":"52","author":"Xiao","year":"2015","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.jep.2023.116740_bib213","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.yebeh.2017.10.010","article-title":"Epilepsy is a neurological and a systemic disorder","volume":"78","author":"Yuen","year":"2018","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.jep.2023.116740_bib214","doi-asserted-by":"crossref","first-page":"6964","DOI":"10.1523\/JNEUROSCI.0066-09.2009","article-title":"The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy","volume":"29","author":"Zeng","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jep.2023.116740_bib215","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ana.21331","article-title":"Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex","volume":"63","author":"Zeng","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jep.2023.116740_bib216","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.molimm.2019.09.020","article-title":"Curcumin inhibits LPS-induced neuroinflammation by promoting microglial M2 polarization via TREM2\/TLR4\/NF-\u03baB pathways in BV2 cells","volume":"116","author":"Zhang","year":"2019","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jep.2023.116740_bib218","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1745-7254.2007.00486.x","article-title":"Drug brain distribution following intranasal administration of Huperzine A in situ gel in rats","volume":"28","author":"Zhao","year":"2007","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.jep.2023.116740_bib219","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1142\/S0192415X18500374","article-title":"Excavating anticonvulsant compounds from prescriptions of traditional Chinese medicine in the treatment of epilepsy","volume":"46","author":"Zhao","year":"2018","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.jep.2023.116740_bib220","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/epi.12463","article-title":"Medicinal compounds with antiepileptic\/anticonvulsant activities","volume":"55","author":"Zhu","year":"2014","journal-title":"Epilepsia"},{"issue":"Suppl. 2","key":"10.1016\/j.jep.2023.116740_bib221","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1590\/S0074-02761991000600039","article-title":"Development of natural products as drugs acting on central nervous system","volume":"86","author":"Zhu","year":"1991","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.jep.2023.116740_bib222","first-page":"641","article-title":"Exogenous melatonin abolishes mechanical allodynia but not thermal hyperalgesia in neuropathic pain. The role of the opioid system and benzodiazepine-gabaergic mechanism","volume":"63","author":"Zurowski","year":"2012","journal-title":"J. Physiol. Pharmacol. an Off. J. Polish Physiol. Soc."}],"container-title":["Journal of Ethnopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874123006086?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874123006086?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T17:44:28Z","timestamp":1777571068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378874123006086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":191,"alternative-id":["S0378874123006086"],"URL":"https:\/\/doi.org\/10.1016\/j.jep.2023.116740","relation":{},"ISSN":["0378-8741"],"issn-type":[{"value":"0378-8741","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural product-derived therapies for treating drug-resistant epilepsies: From ethnopharmacology to evidence-based medicine","name":"articletitle","label":"Article Title"},{"value":"Journal of Ethnopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jep.2023.116740","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116740"}}